Reported results
- Total revenue was $0.3 million for the quarter ended September 30, 2026, compared to $0.5 million for the quarter ended September 30, 2025.
- Net income for the quarter ended September 30, 2026 was $59.1 million, or $0.30 per basic and diluted common share, compared to a net loss of $7.7 million, or $0.04 per basic and diluted common share, for the quarter ended September 30, 2025.
- Research and development expenses were $2.6 million for the quarter ended September 30, 2026, compared to $5.8 million for the same period in 2025.
- General and administrative expenses were $8.0 million for the quarter ended September 30, 2026, compared to $3.0 million for the same period in 2025.
- Cash, cash equivalents and investments in marketable securities were $337.5 million as of September 30, 2026, compared to $91.5 million as of December 31, 2025.
Price and volatility reaction
The stock moved +2.7% on the print. No front-expiry chain was on file, so there is no straddle expected move. 30-day ATM implied volatility moved +10.0 vol points across the event (constant-maturity series — not the front-week crush).
| Measure | Value | Basis |
|---|---|---|
| Close before release | 3.72 | 2026-11-09 |
| Close after release | 3.82 | 2026-11-10 |
| Realised move | +2.7% | close to close |
| 30d ATM IV change | +10.0 vol pts | constant-maturity series, not the front expiry |
Source
The figures above come from the earnings release the company filed with the SEC on 2026-11-10 (8-K, Item 2.02). Read the original filing on sec.gov.
